<?xml version="1.0" encoding="UTF-8"?>
<p>HIV-2 shares structural, antigenic, and genomic characteristics as HIV-1, although it shows a vastly different pathogenic ability in the human host [
 <xref rid="B24-jcm-09-02661" ref-type="bibr">24</xref>]. HIV-2 has a lower infectivity, longer asymptomatic phase, and slower progression to AIDS than HIV-1 [
 <xref rid="B25-jcm-09-02661" ref-type="bibr">25</xref>]. Like HIV-1, HIV-2 has a surface envelope glycoprotein that binds to co-receptor CD4, but at a lower affinity than HIV-1, possibly contributing to the differences seen between HIV-1 and HIV-2 [
 <xref rid="B24-jcm-09-02661" ref-type="bibr">24</xref>].
</p>
